Clinical evaluation of apomorphine HCl
Nagai, A.; Kumon, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 6): 457-460
2002
ISSN/ISBN: 0047-1852 PMID: 12166200 Document Number: 546523
Document emailed within 1 workday
Related Documents
Rudzińska, M.; Szczudlik, A. 2007: Apomorphine in off state--clinical experience Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S40-S48Castaigne, P.; Laplane, D.; Dordain, G. 1971: Clinical experimentation with apomorphine in Parkinson's disease Research Communications in Chemical Pathology and Pharmacology 2(2): 154-158
Kronfly Rubiano, E.; Ricarte Díez, Jé.I.; Juncosa Font, Sán.; Martínez Carretero, J.Maria. 2007: Evaluation of the clinical competence of Catalonian medicine schools 1994-2006. Evolution of examination formats until the objective and structured clinical evaluation (ECOE) Medicina clinica 129(20): 777-784
Allen, E.D.; Byrd, S.E.; Darling, C.F.; Tomita, T.; Wilczynski, M.A. 1993: The clinical and radiological evaluation of primary brain tumors in children, Part I: Clinical evaluation Journal of the National Medical Association 85(6): 445-451
Saura-Llamas, J.; Saturno Hernández, P.J.; Gascón Cánovas, J.J.; López Montesinos, M.J.; Gaona Ramón, J.M. 1999: The evaluation of the quality of so-called "clinical protocols" in primary care developed in the Autonomous Community of Murcia. the Group for the Evaluation and Improvement of Clinical Protocols Atencion Primaria 23(4): 204-210
Blettery, B.; Andre, F.; Virot, C.; Escousse, A. 1986: Is apomorphine still usable? Presse Medicale 15(27): 1287
Pinder, R.M.; Buxton, D.A.; Woodruff, G.N. 1972: On apomorphine and dopamine receptors Journal of Pharmacy and Pharmacology 24(11): 903-904
Giménez-Roldán, S.; García- Muñozguren, S. 2002: Use of apomorphine in Parkinson s disease Revista de Neurologia 35(7): 668-674
Carlsson, C.; Fasth, B.G. 1974: Apomorphine and propranolol in the treatment of alcoholism Lakartidningen 71(34): 3074-3076
Beymer, C.H.; Quock, R.M. 1977: Molindone: an apomorphine antagonist in the rabbit Communications in Psychopharmacology 1(4): 385-392
Stoliarov, G.V.; Markova, O.F. 1982: Apomorphine in dyskinesia and psychomotor agitation Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 82(8): 97-102
Ziegler, B.; Schneider, E. 1974: Treatment of withdrawal syndrome with apomorphine Arzneimittel-Forschung 24(8): 1117-1119
Jones 1998: Careful Evaluation of Clinical and Pre-Clinical Data is Needed -- not more Clinical Trials! Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 2(6): 308-310
Chacón, J.é R.; Mata, M. 2012: Candidate patient for subcutaneous apomorphine injection Revista de Neurologia 55(Suppl 1): S7-S9
Dlabac, A. 1973: Apomorphine--induced aggressivity in rats and its alterations Activitas Nervosa Superior 15(2): 133
Erhardt, P.W.; Smith, R.V.; Sayther, T.T.; Keiser, J.E. 1976: Thin-layer chromatography of apomorphine and its analogs Journal of Chromatography 116(1): 218-224
Springer, V.; Struhár, M.; Heliová, M.; Majer, J.; Chalabala, M. 1974: D-(-) penicillamine as a stabilizer of apomorphine chloride solutions Ceskoslovenska Farmacie 23(9): 356-358
2005: Apomorphine (Apokyn) for advanced Parkinson's Disease Medical Letter on Drugs and Therapeutics 47(1200): 7-8
Piccini, P.; Del Dotto, P.; Napolitano, A.; Pardini, C.; Bonuccelli, U. 1990: The apomorphine test for diagnosis of parkinsonian syndrome Rivista di Neurologia 60(6): 221-223
Melzacka, M.; Wiszniowska, G.; Daniel, W.; Vetulani, J. 1979: Haloperidol-induced changes in the regional cerebral pharmacokinetics of apomorphine Polish Journal of Pharmacology and Pharmacy 31(4): 387-391